Xilio Therapeutics Inc (XLO)
0.96
-0.06
(-5.88%)
USD |
NASDAQ |
Jun 17, 13:07
Xilio Therapeutics Price to Book Value: 1.375 for June 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 1.461 |
| June 13, 2024 | 1.504 |
| June 12, 2024 | 1.519 |
| June 11, 2024 | 1.605 |
| June 10, 2024 | 1.519 |
| June 07, 2024 | 1.504 |
| June 06, 2024 | 1.461 |
| June 05, 2024 | 1.461 |
| June 04, 2024 | 1.547 |
| June 03, 2024 | 1.504 |
| May 31, 2024 | 1.547 |
| May 30, 2024 | 1.332 |
| May 29, 2024 | 1.341 |
| May 28, 2024 | 1.314 |
| May 24, 2024 | 1.504 |
| May 23, 2024 | 1.533 |
| May 22, 2024 | 1.648 |
| May 21, 2024 | 1.719 |
| May 20, 2024 | 1.791 |
| May 17, 2024 | 1.633 |
| May 16, 2024 | 1.547 |
| May 15, 2024 | 1.605 |
| May 14, 2024 | 1.562 |
| May 13, 2024 | 1.605 |
| May 10, 2024 | 1.690 |
| Date | Value |
|---|---|
| May 09, 2024 | 1.805 |
| May 08, 2024 | 1.734 |
| May 07, 2024 | 1.805 |
| May 06, 2024 | 1.791 |
| May 03, 2024 | 1.690 |
| May 02, 2024 | 1.504 |
| May 01, 2024 | 1.547 |
| April 30, 2024 | 1.49 |
| April 29, 2024 | 1.49 |
| April 26, 2024 | 1.562 |
| April 25, 2024 | 1.447 |
| April 24, 2024 | 1.519 |
| April 23, 2024 | 1.504 |
| April 22, 2024 | 1.576 |
| April 19, 2024 | 1.648 |
| April 18, 2024 | 1.834 |
| April 17, 2024 | 1.762 |
| April 16, 2024 | 1.862 |
| April 15, 2024 | 1.805 |
| April 12, 2024 | 1.690 |
| April 11, 2024 | 1.820 |
| April 10, 2024 | 1.713 |
| April 09, 2024 | 1.753 |
| April 08, 2024 | 1.967 |
| April 05, 2024 | 1.606 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2625
Minimum
Dec 20 2023
2.368
Maximum
Jan 03 2022
0.9057
Average
0.8142
Median
Price to Book Value Benchmarks
| Gilead Sciences Inc | 4.589 |
| FibroGen Inc | -- |
| Avalo Therapeutics Inc | -- |
| IGM Biosciences Inc | 2.610 |
| AEON Biopharma Inc | -- |
Price to Book Value Related Metrics
| Price | 0.96 |
| Earnings Yield | -267.7% |
| Market Cap | 35.44M |